Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cristina balla (68 results)?
NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.
Catalano G, Niscola P, Banella C, Diverio D, Trawinska MM, Fratoni S, Iazzoni R, De Fabritiis P, Abruzzese E, Noguera NI. Catalano G, et al. Among authors: banella c. Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020083. doi: 10.4084/MJHID.2020.083. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 33194157 Free PMC article. Review.
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Catalano G, Zaza A, Banella C, Pelosi E, Castelli G, de Marinis E, Smigliani A, Travaglini S, Ottone T, Divona M, Del Principe MI, Buccisano F, Maurillo L, Ammatuna E, Testa U, Nervi C, Venditti A, Voso MT, Noguera NI. Catalano G, et al. Among authors: banella c. Leukemia. 2023 Aug;37(8):1600-1610. doi: 10.1038/s41375-023-01946-5. Epub 2023 Jun 22. Leukemia. 2023. PMID: 37349598
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Travaglini S, Ottone T, Angelini DF, Fiori V, Dominici S, Noguera NI, Śniegocka M, Antonelli S, Irno Consalvo MA, De Bardi M, Banella C, Divona M, Marchesi F, Masciarelli S, Fazi F, Pieraccioli M, Palmieri R, De Angelis G, Buccisano F, Venditti A, Battistini L, Magnani M, Voso MT. Travaglini S, et al. Among authors: banella c. Leukemia. 2022 Jun;36(6):1685-1688. doi: 10.1038/s41375-022-01566-5. Epub 2022 Apr 14. Leukemia. 2022. PMID: 35422094 No abstract available.
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
Banella C, Catalano G, Travaglini S, Pelosi E, Ottone T, Zaza A, Guerrera G, Angelini DF, Niscola P, Divona M, Battistini L, Screnci M, Ammatuna E, Testa U, Nervi C, Voso MT, Noguera NI. Banella C, et al. Cancers (Basel). 2022 May 23;14(10):2565. doi: 10.3390/cancers14102565. Cancers (Basel). 2022. PMID: 35626170 Free PMC article.
PML/RARA inhibits expression of HSP90 and its target AKT.
Piredda ML, Gaur G, Catalano G, Divona M, Banella C, Travaglini S, Puzzangara MC, Voso MT, Lo-Coco F, Noguera NI. Piredda ML, et al. Among authors: banella c. Br J Haematol. 2019 Mar;184(6):937-948. doi: 10.1111/bjh.15715. Epub 2018 Dec 9. Br J Haematol. 2019. PMID: 30536958 Free article.
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.
Quattrocchi A, Maiorca C, Billi M, Tomassini S, De Marinis E, Cenfra N, Equitani F, Gentile M, Ceccherelli A, Banella C, Mecarocci S, Scerpa MC, Pisanò S, Pacilli A, Di Cristofano C, Mancini M, Guglielmelli P, Vannucchi AM, Noguera N, Grignani F, Cimino G, Nervi C. Quattrocchi A, et al. Among authors: banella c. Am J Hematol. 2020 Oct;95(10):E263-E267. doi: 10.1002/ajh.25911. Epub 2020 Jul 20. Am J Hematol. 2020. PMID: 32572989 Free article. No abstract available.